- Home
- GPRE vs CADL Comparison
GPRE vs CADL Comparison
Compare GPRE & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRE
- CADL
- Stock Information
- Founded
- GPRE 2004
- CADL 1999
- Country
- GPRE United States
- CADL United States
- Employees
- GPRE N/A
- CADL N/A
- Industry
- GPRE Major Chemicals
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- GPRE Industrials
- CADL Health Care
- Exchange
- GPRE Nasdaq
- CADL Nasdaq
- Market Cap
- GPRE 289.7M
- CADL 252.0M
- IPO Year
- GPRE N/A
- CADL 2021
- Fundamental
- Price
- GPRE $7.21
- CADL $6.16
- Analyst Decision
- GPRE Buy
- CADL Strong Buy
- Analyst Count
- GPRE 7
- CADL 5
- Target Price
- GPRE $10.42
- CADL $21.40
- AVG Volume (30 Days)
- GPRE 2.0M
- CADL 866.1K
- Earning Date
- GPRE 08-05-2025
- CADL 08-12-2025
- Dividend Yield
- GPRE N/A
- CADL N/A
- EPS Growth
- GPRE N/A
- CADL N/A
- EPS
- GPRE N/A
- CADL N/A
- Revenue
- GPRE $2,463,097,000.00
- CADL N/A
- Revenue This Year
- GPRE $2.90
- CADL N/A
- Revenue Next Year
- GPRE $1.54
- CADL N/A
- P/E Ratio
- GPRE N/A
- CADL N/A
- Revenue Growth
- GPRE N/A
- CADL N/A
- 52 Week Low
- GPRE $3.14
- CADL $3.79
- 52 Week High
- GPRE $18.14
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- GPRE 84.31
- CADL 57.20
- Support Level
- GPRE $5.60
- CADL $4.86
- Resistance Level
- GPRE $5.88
- CADL $5.12
- Average True Range (ATR)
- GPRE 0.37
- CADL 0.28
- MACD
- GPRE 0.13
- CADL 0.06
- Stochastic Oscillator
- GPRE 97.16
- CADL 88.26
About GPRE Green Plains Inc.
Green Plains Inc manufactures and sells ethanol and ethanol byproducts in two segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.